Track papers across labs, topics, and trends.
Search papers, labs, and topics across Lattice.
The authors develop Batch-Aligned Tail Arbitration (BATA), an active learning framework for protein design that dynamically arbitrates between zero-shot biological priors and task-specific surrogate models using iterative wet-lab feedback. Existing sequence optimization strategies often fail to maintain reliable candidate rankings in the extreme high-fitness regime as empirical measurements accumulate under tight experimental budgets. Evaluated across the GB1, PABP, and TrpB empirical fitness landscapes, BATA achieves a top-performing mean task rank of 1.67 in discovered peak fitness within an allocation of only 480 measurements.
Static protein surrogates fail as experimental evidence shifts, but dynamically arbitrating between zero-shot priors and task models exclusively at the high-fitness tail reliably surfaces top variants in under 500 wet-lab measurements.
Protein optimization aims to discover high-fitness sequences under a limited experimental budget. Existing machine-learning methods use task-specific predictors, biological priors, or ranking-aware objectives to guide which variants are tested in the next experimental round. However, these methods cannot adapt to shifts in the reliability of predictive evidence as measurements accumulate and ensure the correct ranking of key high-fitness candidates. To address these challenges, we propose Batch-Aligned Tail Arbitration (BATA), which uses experimental feedback to adaptively combine prior-informed and task-specific rankings for next-batch selection, with calibration focused on the batch-aligned high-fitness region. Across measured GB1, PABP, and TrpB landscapes, BATA achieves the best mean task rank (1.67) in final best fitness after 480 measurements. Controlled comparisons further show task-dependent gains from high-fitness calibration and batch alignment. Our work introduces feedback-calibrated predictor arbitration, where experimental feedback dynamically determines how predictive evidence guides next-batch selection, opening a new direction for protein optimization.